Currently out of the existing stock ratings of Jason Cassorla, 106 are a BUY (87.6%), 15 are a HOLD (12.4%).

Jason Cassorla

Work Performance Price Targets & Ratings Chart

Analyst Jason Cassorla, currently employed at GUGGENHEIM, carries an average stock price target met ratio of 54.83% that have a potential upside of 34.1% achieved within 251 days.

Jason Cassorla’s has documented 233 price targets and ratings displayed on 19 stocks. The coverage is on the Healthcare sector.

Most recent stock forecast was given on ELV, Elevance Health.

Wall Street Analyst Jason Cassorla

Analyst best performing recommendations are on ACHC (ACADIA HEALTHCARE COMPANY).
The best stock recommendation documented was for ACHC (ACADIA HEALTHCARE COMPANY) at 2/23/2026. The price target of $22 was fulfilled within 3 days with a profit of $4.62 (26.58%) receiving and performance score of 88.61.

Average potential price target upside

AGTI Agiliti BHG Bright Health Group CANO Cano Health CYH Community Health Systems HCA HCA Holdings SGRY Surgery Partners THC Tenet Healthcare CLOV Clover Health Investments Corp UHS Universal Health Services EHAB Enhabit INNV InnovAge Holding Corp PACS PACS Group ACHC Acadia Healthcare Company CI Cigna Corp CNC Centene Corp ELV Elevance Health HUM Humana AG First Majestic Silver Corp ARDT Ardent Health Partners

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date of last PT

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Hold Since 26-Mar-2024

2 years 6 months 27 days ago
(26-Mar-2024)

1/6 (16.67%)

$4.31 (27.47%)

48

Buy Since 07-Mar-2024

$10

$-0.05 (-0.50%)

$10

2 years 7 months 16 days ago
(07-Mar-2024)

4/5 (80%)

$0.1 (1.01%)

46

Buy Since 25-Sep-2023

$10.5

2 years 7 months 26 days ago
(27-Feb-2024)

0/1 (0%)

$3.69 (54.19%)

Sell Since 14-Nov-2023

$8

2 years 7 months 27 days ago
(26-Feb-2024)

5/10 (50%)

$0.17 (2.17%)

18

Hold Since 09-Aug-2023

$11

$0.95 (9.45%)

$18

3 years 1 months 18 days ago
(05-Sep-2023)

1/3 (33.33%)

$2.29 (26.29%)

49

Show more analysts

Please expand the browser size to see the chart

Which stock is Jason Cassorla most bullish on?

Potential upside of $58.7 has been obtained for CI (CIGNA CORP)

Which stock is Jason Cassorla most reserved on?

Potential downside of $2.05 has been obtained for ARDT (ARDENT HEALTH PARTNERS)

What Year was the first public recommendation made by Jason Cassorla?

On 2017
✖

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?